198 related articles for article (PubMed ID: 11803913)
1. Screening for colorectal cancer.
Launoy G
N Engl J Med; 2001 Dec; 345(25):1850-1; author reply 1851-2. PubMed ID: 11803913
[No Abstract] [Full Text] [Related]
2. Screening for colorectal cancer.
Allison JE; Selby J
N Engl J Med; 2001 Dec; 345(25):1850; author reply 1851-2. PubMed ID: 11752366
[No Abstract] [Full Text] [Related]
3. Colorectal carcinoma: is screening possible?
Bonelli L
Tech Coloproctol; 2004 Dec; 8 Suppl 2():s267-72. PubMed ID: 15666104
[TBL] [Abstract][Full Text] [Related]
4. Random comparison of guaiac and immunochemical fecal occult blood tests for colorectal cancer in a screening population.
van Rossum LG; van Rijn AF; Laheij RJ; van Oijen MG; Fockens P; van Krieken HH; Verbeek AL; Jansen JB; Dekker E
Gastroenterology; 2008 Jul; 135(1):82-90. PubMed ID: 18482589
[TBL] [Abstract][Full Text] [Related]
5. Colon cancer screening: where have we come from and where do we go?
Chorost MI; Datta R; Santiago RC; Lee B; Bollman J; Leitman IM; Ghosh BC
J Surg Oncol; 2004 Jan; 85(1):7-13. PubMed ID: 14696082
[No Abstract] [Full Text] [Related]
6. Updated guidelines call for higher colorectal cancer screening rates.
Rollins G
Rep Med Guidel Outcomes Res; 2001 Apr; 12(7):5-7. PubMed ID: 12075629
[No Abstract] [Full Text] [Related]
7. Screening for colorectal cancer.
Finkelstein C; Goss JR
N Engl J Med; 2001 Dec; 345(25):1851; author reply 1851-2. PubMed ID: 11803915
[No Abstract] [Full Text] [Related]
8. Randomized trial of different screening strategies for colorectal cancer: patient response and detection rates.
Segnan N; Senore C; Andreoni B; Arrigoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; DiPlacido R; Ferrari A; Ferraris R; Ferrero F; Fracchia M; Gasperoni S; Malfitana G; Recchia S; Risio M; Rizzetto M; Saracco G; Spandre M; Turco D; Turco P; Zappa M;
J Natl Cancer Inst; 2005 Mar; 97(5):347-57. PubMed ID: 15741571
[TBL] [Abstract][Full Text] [Related]
9. Screening for colorectal neoplasms with new fecal occult blood tests: update on performance characteristics.
Allison JE; Sakoda LC; Levin TR; Tucker JP; Tekawa IS; Cuff T; Pauly MP; Shlager L; Palitz AM; Zhao WK; Schwartz JS; Ransohoff DF; Selby JV
J Natl Cancer Inst; 2007 Oct; 99(19):1462-70. PubMed ID: 17895475
[TBL] [Abstract][Full Text] [Related]
10. Which colorectal cancer screening test is best?
Mandel JS
J Natl Cancer Inst; 2007 Oct; 99(19):1424-5. PubMed ID: 17895471
[No Abstract] [Full Text] [Related]
11. Comparing attendance and detection rate of colonoscopy with sigmoidoscopy and FIT for colorectal cancer screening.
Segnan N; Senore C; Andreoni B; Azzoni A; Bisanti L; Cardelli A; Castiglione G; Crosta C; Ederle A; Fantin A; Ferrari A; Fracchia M; Ferrero F; Gasperoni S; Recchia S; Risio M; Rubeca T; Saracco G; Zappa M;
Gastroenterology; 2007 Jun; 132(7):2304-12. PubMed ID: 17570205
[TBL] [Abstract][Full Text] [Related]
12. Incremental advances in excremental cancer detection tests.
Itzkowitz SH
J Natl Cancer Inst; 2009 Sep; 101(18):1225-7. PubMed ID: 19700654
[No Abstract] [Full Text] [Related]
13. Identification of colorectal adenomas by a quantitative immunochemical faecal occult blood screening test depends on adenoma characteristics, development threshold used and number of tests performed.
Rozen P; Levi Z; Hazazi R; Waked A; Vilkin A; Maoz E; Birkenfeld S; Leshno M; Niv Y
Aliment Pharmacol Ther; 2009 Apr; 29(8):906-17. PubMed ID: 19183147
[TBL] [Abstract][Full Text] [Related]
14. Comparison of CT colonography, colonoscopy, sigmoidoscopy and faecal occult blood tests for the detection of advanced adenoma in an average risk population.
Graser A; Stieber P; Nagel D; Schäfer C; Horst D; Becker CR; Nikolaou K; Lottes A; Geisbüsch S; Kramer H; Wagner AC; Diepolder H; Schirra J; Roth HJ; Seidel D; Göke B; Reiser MF; Kolligs FT
Gut; 2009 Feb; 58(2):241-8. PubMed ID: 18852257
[TBL] [Abstract][Full Text] [Related]
15. Predictive value of diminutive colonic adenoma trial: the PREDICT trial.
Schoenfeld P; Shad J; Ormseth E; Coyle W; Cash B; Butler J; Schindler W; Kikendall WJ; Furlong C; Sobin LH; Hobbs CM; Cruess D; Rex D;
Clin Gastroenterol Hepatol; 2003 May; 1(3):195-201. PubMed ID: 15017491
[TBL] [Abstract][Full Text] [Related]
16. The case for population-based screening for colorectal cancer.
Schoen RE
Nat Rev Cancer; 2002 Jan; 2(1):65-70. PubMed ID: 11902587
[TBL] [Abstract][Full Text] [Related]
17. Screening for colorectal cancer.
Atlas SA
N Engl J Med; 2001 Dec; 345(25):1851; author reply 1851-2. PubMed ID: 11803914
[No Abstract] [Full Text] [Related]
18. Can quantification of faecal occult blood predetermine the need for colonoscopy in patients at risk for non-syndromic familial colorectal cancer?
Levi Z; Rozen P; Hazazi R; Vilkin A; Waked A; Maoz E; Birkenfeld S; Niv Y
Aliment Pharmacol Ther; 2006 Nov; 24(10):1475-81. PubMed ID: 17032281
[TBL] [Abstract][Full Text] [Related]
19. Predictors of colorectal cancer screening participation in the United States.
Ioannou GN; Chapko MK; Dominitz JA
Am J Gastroenterol; 2003 Sep; 98(9):2082-91. PubMed ID: 14499792
[TBL] [Abstract][Full Text] [Related]
20. Screening for colorectal cancer.
Wendt E
N Engl J Med; 2001 Dec; 345(25):1851; author reply 1852. PubMed ID: 11803918
[No Abstract] [Full Text] [Related]
[Next] [New Search]
